NHS warning over symptoms of rare disorder that could be mistaken for the flu
The NHS has issued a warning over how similar flu symptoms are to a rare disorder which you need to look out for. Many of us ...
The rare disorder the NHS says could be mistaken for the flu
The NHS is cautioning that during this time of year, it might be easy to confuse flu symptoms with those of a rare condition.
You may have rare disorder rather than the flu, says NHS
The NHS is warning that at this time of year, it could be easy to mistake having the flu for a rare disorder. Addison's ...
"Todd Mack" MacGillivray, founder of Chicago's Foursided framing and gift shops, dies at 57
A published obituary​ said MacGillivray, who was known to all as Todd Mack, died Tuesday, Jan. 7, after a lifelong battle ...
Rolling Out4d
The truth about adrenal cocktails and stress
Explore the facts behind adrenal cocktails, their claimed benefits, potential risks, and why experts recommend focusing on ...
dermatologyadvisor4d
Primary Ovarian Insufficiency Linked to Higher Autoimmune Disease Risk
Primary ovarian insufficiency was associated with a higher risk for autoimmune conditions including hypothyroidism and adrenal insufficiency.
manilatimes4d
Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)
The TouCAHn trial is an open-label, global, Phase 2 study designed to evaluate the efficacy, safety, and pharmacokinetics of ...
Medpage Today on MSN8h
T1D Islet Cell Transplant; 50K Processed Foods Ranked; Obesity and Childhood Cancers
Sana Biotechnology said a type 1 diabetes (T1D) patient received an allogeneic primary islet cell transplantation without ...
Crinetics announces results from Phase 2 trial of atumelnant
Pharmaceuticals announced positive topline results from an open-label, Phase 2 congenital adrenal hyperplasia, CAH, study of ...
Too Old to Operate5d
Increased NAFLD Risk in MACS with Serum Cortisol as a Key Predictor
The following is a summary of “Prevalence and Predictive Features of CT-Derived Nonalcoholic Fatty Liver Disease in ...
Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CRNX) today announced that on January 10, 2025, the Compensation ...
Crinetics falls after mid-stage trial data adrenal disorder therapy
Crinetics Pharmaceuticals (CRNX) stock fell after Phase 2 results for its experimental drug atumelnant for congenital adrenal hyperplasia. Read more here.